| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 26.326 | 8.537 | 14.118 | - | 47.221 | 24.981 | 7.540 | 3.827 | 44.089 |
| Total Income - EUR | - | 26.326 | 8.537 | 14.118 | - | 47.221 | 24.981 | 7.540 | 3.827 | 59.851 |
| Total Expenses - EUR | - | 24.467 | 5.116 | 12.659 | - | 70.323 | 36.277 | 16.997 | 7.333 | 60.650 |
| Gross Profit/Loss - EUR | - | 1.860 | 3.421 | 1.460 | - | -23.102 | -11.296 | -9.457 | -3.506 | -799 |
| Net Profit/Loss - EUR | - | 1.519 | 3.413 | 1.319 | - | -23.575 | -11.546 | -9.533 | -3.545 | -1.398 |
| Employees | - | 3 | 1 | 2 | - | 2 | 3 | 3 | 2 | 0 |
Check the financial reports for the company - Myotech Supplements Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 113 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 3.510 | 3.868 | 5.585 | - | 7.562 | 4.329 | 1.253 | 1.249 | 108.766 |
| Inventories | - | 1.848 | 0 | 0 | - | 883 | 3.051 | 1.253 | 1.249 | 33.346 |
| Receivables | - | 0 | 0 | 0 | - | 0 | 1.278 | 0 | 0 | 1.006 |
| Cash | - | 1.662 | 3.868 | 5.585 | - | 6.679 | 0 | 0 | 0 | 74.414 |
| Shareholders Funds | - | 1.564 | 3.456 | 4.712 | - | -18.280 | -29.421 | -39.045 | -3.504 | -1.358 |
| Social Capital | - | 45 | 44 | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.059 | 412 | 873 | - | 25.842 | 33.750 | 40.297 | 4.753 | 110.124 |
| Income in Advance | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Myotech Supplements Srl